An analysis of growth, differentiation and apoptosis genes with risk of renal cancer

PLoS ONE

Volumn 4, Issue 3, 2009, Pages

  Dong, Linda M ^a   Brennan, Paul ^b   Karami, Sara ^a   Hung, Rayjean J ^c   Menashe, Idan ^a   Berndt, Sonja I ^a   Yeager, Meredith ^a   Chanock, Stephen ^a   Zaridze, David ^d   Matveev, Vsevolod ^d   Janout, Vladimir ^e   Kollarova, Hellena ^e   Bencko, Vladimir ^f   Schwartz, Kendra ^g   Davis, Faith ^h   Navratilova, Marie ⁱ   Szeszenia Dabrowska, Neonila ^j   Mates, Dana ^k   Colt, Joanne S ^a   Holcatova, Ivana ^f   Boffetta, Paolo ^c   Rothman, Nathaniel ^a   Chow, Wong Ho ^a   Rosenberg, Philip S ^a   Moore, Lee E ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c MOUNT SINAI HOSPITAL   (Canada)

^d Institute of Carcinogenesis   (Russian Federation)

^e PALACKÝ UNIVERSITY   (Czech Republic)

^f CHARLES UNIVERSITY   (Czech Republic)

^g WAYNE STATE UNIVERSITY   (United States)

^h UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

ⁱ MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^j NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^k NATIONAL INSTITUTE OF PUBLIC HEALTH   (Romania)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CASPASE 12; CASPASE 4; CASPASE 5; CYTOSINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GENOMIC DNA; GUANOSINE; INTERLEUKIN 1BETA CONVERTING ENZYME; SOMATOMEDIN BINDING PROTEIN 3; THYMIDINE;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GENETICS; CANCER RISK; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CHROMOSOME ANALYSIS; CONTROLLED STUDY; EXON; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN TISSUE; INTRON; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; ONCOGENE; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; CELL PROLIFERATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; KIDNEY TUMOR; MIDDLE AGED; RISK FACTOR;

ADULT; APOPTOSIS; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 63449119614     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004895     Document Type: Article

References (49)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
2. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, et al. (2008) Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44: 1345-1389.
3. Chow WH, Devesa SS (2008) Contemporary epidemiology of renal cell cancer. Cancer J 14: 288-301.
4. Mathew A, Devesa SS, Fraumeni JF Jr, Chow WH (2002) Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev 11: 171-178.
5. Levi F, Ferlay J, Galeone C, Lucchini F, Negri E, et al. (2008) The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int 101: 949-958.
6. McLaughlin JK, Lipworth L, Tarone RE, Blot WJ (2006) Renal Cancer. In: Schottenfeld D, Fraumeni JF, eds. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press.
7. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70.
8. Aaronson SA (1991) Growth factors and cancer. Science 254: 1146-1153.
9. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281: 1312-1316.
10. Breast Cancer Association C (2006) Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst 98: 1382-1396.
11. Hosgood HD 3rd, Menashe I, Shen M, Yeager M, Yuenger J, et al. (2008) Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. Carcinogenesis 29: 1938-1943.
12. Moore LE, Brennan P, Karami S, Hung RJ, Hsu C, et al. (2007) Glutathione S-transferase polymorphisms, cruciferous vegetable intake and cancer risk in the Central and Eastern European Kidney Cancer Study. Carcinogenesis 28: 1960-1964.
13. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, et al. (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74: 106-120.
14. Packer BR, Yeager M, Burdett L, Welch R, Beerman M, et al. (2006) SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 34: D617-621.
15. Rosenberg PS, Che A, Chen BE (2006) Multiple hypothesis testing strategies for genetic case-control association studies. Stat Med 25: 3134-3149.
16. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B (Methodological) 57: 289-300.
17. Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, et al. (2006) Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366: 2-16.
18. Tabernero J, Macarulla T, Ramos FJ, Baselga J (2005) Novel targeted therapies in the treatment of gastric and esophageal cancer. Ann Oncol 16: 1740-1748.
19. Weihua Z, Tsan R, Huang WC, Wu Q, Chiu CH, et al. (2008) Survival of cancer cells is maintained by EGFR independent of its kinase activity. Cancer Cell 13: 385-393.
20. Lee WS, Kanai Y, Wells RG, Hediger MA (1994) The high affinity Na+/ glucose cotransporter. Re-evaluation of function and distribution of expression. J Biol Chem 269: 12032-12039.
21. Araujo A, Ribeiro R, Azevedo I, Coelho A, Soares M, et al. (2007) Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer-a review of the literature. Oncologist 12: 201-210.
22. Press OA, Zhang W, Gordon MA, Yang D, Lurje G, et al. (2008) Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer. Cancer Res 68: 3037-3042.
23. Chi DD, Hing AV, Helms C, Steinbrueck T, Mishra SK, et al. (1992) Two chromosome 7 dinucleotide repeat polymorphisms at gene loci epidermal growth factor receptor (EGFR) and pro alpha 2 (I) collagen (COL1A2). Hum Mol Genet 1: 135.
24. Gebhardt F, Burger H, Brandt B (2000) Modulation of EGFR gene transcription by a polymorphic repetitive sequence-a link between genetics and epigenetics. Int J Biol Markers 15: 105-110.
25. Buerger H, Packeisen J, Boecker A, Tidow N, Kersting C, et al. (2004) Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence-first results of an inter-ethnic breast cancer study. J Pathol 203: 545-550.
26. Liu W, Innocenti F, Wu MH, Desai AA, Dolan ME, et al. (2005) A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter. Cancer Res 65: 46-53.
27. Pollak MN, Schernhammer ES, Hankinson SE (2004) Insulin-like growth factors and neoplasia. Nat Rev Cancer 4: 505-518.
28. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, et al. (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363: 1346-1353.
29. Firth SM, Baxter RC (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23: 824-854.
30. Rosendahl AH, Forsberg G (2006) IGF-I and IGFBP-3 augment transforming growth factor-beta actions in human renal carcinoma cells. Kidney Int 70: 1584-1590.
31. Chuang ST, Patton KT, Schafernak KT, Papavero V, Lin F, et al. (2008) Over expression of insulin-like growth factor binding protein 3 in clear cell renal cell carcinoma. J Urol 179: 445-449.
32. Cheung CW, Vesey DA, Nicol DL, Johnson DW (2004) The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation. Kidney Int 65: 1272-1279.
33. Ibanez de Caceres I, Dulaimi E, Hoffman AM, Al-Saleem T, Uzzo RG, et al. (2006) Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res 66: 5021-5028.
34. Hughes TA (2006) Regulation of gene expression by alternative untranslated regions. Trends Genet 22: 119-122.
35. Cheng I, Penney KL, Stram DO, Le Marchand L, Giorgi E, et al. (2006) Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 15: 1993-1997.
36. Patel AV, Cheng I, Canzian F, Le Marchand L, Thun MJ, et al. (2008) IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS ONE 3: e2578.
37. Cheng I, DeLellis Henderson K, Haiman CA, Kolonel LN, Henderson BE, et al. (2007) Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population. J Clin Endocrinol Metab 92: 3660-3666.
38. Martinon F, Tschopp J (2007) Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 14: 10-22.
39. Nicholson DW (1999) Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 6: 1028-1042.
40. Offman J, Gascoigne K, Bristow F, Macpherson P, Bignami M, et al. (2005) Repeated sequences in CASPASE-5 and FANCD2 but not NF1 are targets for mutation in microsatellite-unstable acute leukemia/myelodysplastic syndrome. Mol Cancer Res 3: 251-260.
41. Hosomi Y, Gemma A, Hosoya Y, Nara M, Okano T, et al. (2003) Somatic mutation of the Caspase-5 gene in human lung cancer. Int J Mol Med 12: 443-446.
42. Yamaguchi T, Iijima T, Mori T, Takahashi K, Matsumoto H, et al. (2006) Accumulation profile of frameshift mutations during development and progression of colorectal cancer from patients with hereditary nonpolyposis colorectal cancer. Dis Colon Rectum 49: 399-406.
43. Soung YH, Jeong EG, Ahn CH, Kim SS, Song SY, et al. (2008) Mutational analysis of caspase 1, 4, and 5 genes in common human cancers. Hum Pathol 39: 895-900.
44. Lin J, Pu X, Wang W, Matin S, Tannir NM, et al. (2008) Case-Control Analysis of Nucleotide Excision Repair Pathway and the Risk of Renal Cell Carcinoma. Carcinogenesis.
45. Maher ER (1996) Inherited renal cell carcinoma. Br J Urol 78: 542-545.
46. Smith WM, Zhou XP, Kurose K, Gao X, Latif F, et al. (2001) Opposite association of two PPARG variants with cancer: overrepresentation of H449H in endometrial carcinoma cases and underrepresentation of P12A in renal cell carcinoma cases. Hum Genet 109: 146-151.
47. Kawai Y, Sakano S, Korenaga Y, Eguchi S, Naito K (2007) Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas. Eur Urol 52: 1147-1155.
48. Abe A, Sato K, Habuchi T, Wang L, Li Z, et al. (2002) Single nucleotide polymorphisms in the 3′ untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma. Tohoku J Exp Med 198: 181-190.
49. Wacholder S, Rothman N, Caporaso N (2002) Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. Cancer Epidemiol Biomarkers Prev 11: 513-520.